Back to search

National and Kapodistrian University of Athens

Η συμβολή δίαιτας ελλειπούς σε χολίνη στον πειραματικώς επαγόμενο σακχαρώδη διαβήτη σε επίμυες.

Abstract

dc:description

Diabetes Mellitus (DM) is a group of metabolic disorders sharing a common phenotype of hyperglycemia. The metabolic dysregulation related with DM induces secondary pathophysiological alterations in multiple systems leading to metabolic and biological disruptions and histological lesions. Choline (Ch), a B vitamin co-factor, has been identified as an essential nutrient with crucial role in many vital biological functions. It is essential for the structural integrity of the cell membrane and also the transmembranic signaling through the production of secondary messengers. Choline deficiency (CD) can lead to developmental abnormalities, memory disruption, hepatocellular lesions or even oncogenesis in the liver. CD is a common problem met in clinical conditions such as alcoholism, malnutrition, pregnancy and lactation.AIMAim of the study was to investigate the impact of dietary Ch deprivation in a substrate of STZ- induced DM in adult rats. We have searched for potential alterations induced by Ch-deficient diet (CDD) in the changes caused by DM in organs and tissues of rats, especially in the brain, the liver, and adipose tissue and in serum biological parameters.METHODSMale Wistar rats (n=48) age about four months old were randomized into four groups: control (C), STZ induced diabetic (D), Ch-deprived (CD), and Ch-deprived diabetic (D+CD). Deprivation of Ch was provoked through the administration of CDD. Both the induction of DM and the beginning of dietary-mediated provoking of Ch-deprivation occurred at the same day, and rats were killed by decapitation after 30 days and 60 days. We examined the activity of AchE, Na+,K+-ATPase and Mg2+-ATPase in the brain, the expression of MMP-2 and 9, TIMP-1 and 2, GLUT-2 and 4, IRS-1 and IR in the liver, the histopathological lesions in the liver, the leptin, adiponectin, and resistin expression in the adipose tissue and the lipid profile, the liver function tests and the levels of glucose and insulin in the serum at 30 and 60 days of the experiment in order to elucidate the influence of a CDD on the STZ induced DM in the rats.RESULTSThe CD+D group showed high mortality rates (40% in the second month) due to the high toxicity of the combination of a CDD in a diabetic substrate. Also the body weights in this group were less than in the other groups at both months (+20,7% vs +52% in the first month, +1,3% vs 62% in the second). Histological examination of the CDD+D liver sections revealed high grade liposis, in mainly microvescicular, with intense ballooning degeneration. These findings worsened in the second month of the experiment, with liposis becoming macrovescicular. About Liver Function Tests, SGOT and SGPT were significantly increased only by the end of the second month, while γGT and ALP were both statistically increased at both the end of the first and the second month. MMP-2 expression in the liver was non statistically increased in the first month and reduced in the second. MMP-9 expression was increased versus control group by the end of both months, statistically significantly only by the end of the first month. ΤΙΜΡ-1 and 2 expression was slightly upregulated in the combination group by the end of both one and two months. About the lipid profile, serum Triglicerides, Total Cholesterol and HDL were all significantly higher in the CD+D group versus the C group at both the end of the first and the second month. Random serum glucose levels were significantly higher in the CD+D group in the first month, even higher than the D group, but were significantly lower versus the D group by the end of second month. This could mean that CD may enhance glucose tolerance. Fasting serum insulin was significantly lower by the end of second month in the CD+D group versus all other groups (p<0.05). This, in combination with glucose levels that confirm the successful DM induction by STZ, could mean that there was a degree of residual activity of β-cells that secrete insulin inadequately in response to the gradually higher hyperglycemia and also that there was a possible attenuation of the insulin resistance by the CDD. This can be attributed to the sensitized, by CDD, hepatic insulin signaling pathways. GLUT-2 expression in the liver was significantly upregulated (p<0.001) versus C and D groups at both one and two months. IRS-1 and IR expression was also significantly upregulated in the CDD+DM group in both months. GLUT-4 expression on the adipose cells of the liver was upregulated in the CD+D group significantly (p<0.001) versus the C and D groups at both months, due to the fatty liver caused by the CDD.Adiponectin expression in adipose tissue was slightly increased in both months. Leptin expression was upregulated in the first month, but downregulated in the second. Resistin expression was upregulated in both months. The Ch-deprived diabetic rats' brain AChE activity was significantly altered only after a 60-day period of exposure, resulting in a +27% increase (p < 0.001). CD+D group also exhibited a statistically significant decrease in brain Na+,K+ -ATPase activity only in the end end of the second month (-22%, p < 0.01). As concerns Mg2+ -ATPase, the enzyme's activity demonstrates significant increase only by the end of second month (+21%, p < 0.05, D2+CD2 vs. C2).CONCLUSIONOur new design model of combined CD with DM resembles some common clinical conditions, such as patients with insulin dependent diabetes mellitus (IDDM) in combination with malnutrition, parenteral nutrition, pregnancy or lactation and explores the changes in organs, tissues and biochemical parameters induced by the combined effect of Ch deficiency and DM by the end of one and two months of experiment.Our study suggests that CD enhances glucose tolerance in diabetic substrate, attenuating insulin resistance and thus the hyperglycemic response caused by STZ, but at the same time increasing the hepatotoxic and destructive effects of the combination of CDD and DM. Moreover, this combination augmented the features of metabolic syndrome, which is usually simulated by the CD models, by upregulating the expression of Resistin mRNA in adipose tissue and promoting the progressive hyperlipidemia, but with simultaneous weight loss. Our data indicate that Ch-deprivation seems to be an undesiderable background for the above-mentioned enzymatic activities in the brain under untreated diabetes, in a time-evolving way. Further investigations are necessary, in order to elucidate the underlying mechanisms involved in this experimental model and contribute to the search of therapeutic applications for the clinical conditions this model simulates.

Degree

thesis:*
Grantor dc:publisher
National and Kapodistrian University of Athens
Year dc:date
2016

Author and committee

dc:creator, dc:contributor.*
Authors dc:creator
  • Kyriakaki, Argyro
  • Κυριακάκη, Αργυρώ

Subjects

dc:subject × 8

Rights

Language dc:language
gre

Identifiers

dc:identifier.*
Identifier
10.12681/eadd/37139

Chain of custody

source
Harvested from
Greek National Archive of PhD Theses
Base URL
phdtheses.ekt.gr/eadd_oai/request
Last updated
2026-11-18
Source record
OAI-PMH GetRecord
citation

Kyriakaki, Argyro; Κυριακάκη, Αργυρώ. Η συμβολή δίαιτας ελλειπούς σε χολίνη στον πειραματικώς επαγόμενο σακχαρώδη διαβήτη σε επίμυες.. National and Kapodistrian University of Athens, 2016. http://hdl.handle.net/10442/hedi/37139